Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025
Posted On Monday, May 05, 2025
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
Posted On Monday, May 05, 2025
Coherus to Report First Quarter 2025 Financial Results on May 12, 2025
Posted On Monday, May 05, 2025
Syndax Reports First Quarter 2025 Financial Results and Provides Business Update
Posted On Monday, May 05, 2025
Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May
Posted On Monday, May 05, 2025
Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease
Posted On Monday, May 05, 2025
Evolved Extraction Solutions Announces Strategic Expansion in U.S. Market Amid Industry Shakeup
Posted On Monday, May 05, 2025
Arialief Reviews (CRITICAL INVESTIGATION) What Doctors Say About Arialief's Safety And Complaints!
Posted On Monday, May 05, 2025
Arialief Side Effects Investigated: Review the User Complaints, Top Benefits & Ingredients List Before Buy!
Posted On Monday, May 05, 2025
Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference
Posted On Monday, May 05, 2025
First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand
Posted On Monday, May 05, 2025
Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents
Posted On Monday, May 05, 2025
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025
Posted On Monday, May 05, 2025
Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor
Posted On Monday, May 05, 2025
Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025
Posted On Monday, May 05, 2025
Werewolf Therapeutics Presents New Preclinical Data Further Characterizing its IL-10 INDUKINE Molecule, WTX-921, for the Treatment of Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Posted On Monday, May 05, 2025
4DMT to Participate in Upcoming Investor Conferences
Posted On Monday, May 05, 2025
BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth
Posted On Monday, May 05, 2025
CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025
Posted On Monday, May 05, 2025
Werewolf Therapeutics to Participate in Upcoming Investor Conferences
Posted On Monday, May 05, 2025
Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event
Posted On Monday, May 05, 2025
Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision
Posted On Monday, May 05, 2025
IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025
Posted On Monday, May 05, 2025
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
Posted On Monday, May 05, 2025
Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
Posted On Monday, May 05, 2025

Print